Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hilde Brems

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Neuro-Oncology|February 6, 2019
Low mutation burden and frequent loss of CDKN2A/B and SMARCA2, but not PRC2, define premalignant neurofibromatosis type 1-associated atypical neurofibromasAlexander Pemov, Nancy F Hansen, Sivasish Sindiri, et al.
Nature Cell Biology|August 3, 2019
Patient-derived organoids from endometrial disease capture clinical heterogeneity and are amenable to drug screeningMatteo Boretto, Nina Maenhoudt, Xinlong Luo, et al.
European Journal of Cancer (Oxford, England : 1990)|May 28, 2023
PARP inhibitor predictive value of the Leuven HRD test compared with Myriad MyChoice CDx PLUS HRD on 468 ovarian cancer patients from the PAOLA-1/ENGOT-ov25 trialLiselore Loverix, Ignace Vergote, Pieter Busschaert, et al.
Human Mutation|November 20, 2010
Legius syndrome in fourteen familiesEllen Denayer, Magdalena Chmara, Hilde Brems, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 16, 2013
Jaffe-Campanacci syndrome, revisited: detailed clinical and molecular analyses determine whether patients have neurofibromatosis type 1, coincidental manifestations, or a distinct disorderDouglas R Stewart, Hilde Brems, Alicia G Gomes, et al.
Iscience|February 23, 2023
Deep genomic analysis of malignant peripheral nerve sheath tumor cell lines challenges current malignant peripheral nerve sheath tumor diagnosisMiriam Magallón-Lorenz, Ernest Terribas, Sara Ortega-Bertran, et al.
European Journal of Medical Genetics|October 21, 2022
Genotype-phenotype associations in a large PTEN Hamartoma Tumor Syndrome (PHTS) patient cohortLinda A J Hendricks, Nicoline Hoogerbrugge, Hanka Venselaar, et al.
Cancers|March 13, 2024
Lifestyle Factors and Breast Cancer in Females with PTEN Hamartoma Tumor Syndrome (PHTS)Linda A J Hendricks, Katja C J Verbeek, Janneke H M Schuurs-Hoeijmakers, et al.
JAMA|November 19, 2009
Clinical and mutational spectrum of neurofibromatosis type 1-like syndromeLudwine Messiaen, Suxia Yao, Hilde Brems, et al.
Gastroenterology|June 28, 2015
Diagnosis of Constitutional Mismatch Repair-Deficiency Syndrome Based on Microsatellite Instability and Lymphocyte Tolerance to Methylating AgentsSahra Bodo, Chrystelle Colas, Olivier Buhard, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Neuro-Oncology|February 6, 2019
Low mutation burden and frequent loss of CDKN2A/B and SMARCA2, but not PRC2, define premalignant neurofibromatosis type 1-associated atypical neurofibromasAlexander Pemov, Nancy F Hansen, Sivasish Sindiri, et al.
Nature Cell Biology|August 3, 2019
Patient-derived organoids from endometrial disease capture clinical heterogeneity and are amenable to drug screeningMatteo Boretto, Nina Maenhoudt, Xinlong Luo, et al.
European Journal of Cancer (Oxford, England : 1990)|May 28, 2023
PARP inhibitor predictive value of the Leuven HRD test compared with Myriad MyChoice CDx PLUS HRD on 468 ovarian cancer patients from the PAOLA-1/ENGOT-ov25 trialLiselore Loverix, Ignace Vergote, Pieter Busschaert, et al.
Human Mutation|November 20, 2010
Legius syndrome in fourteen familiesEllen Denayer, Magdalena Chmara, Hilde Brems, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 16, 2013
Jaffe-Campanacci syndrome, revisited: detailed clinical and molecular analyses determine whether patients have neurofibromatosis type 1, coincidental manifestations, or a distinct disorderDouglas R Stewart, Hilde Brems, Alicia G Gomes, et al.
Iscience|February 23, 2023
Deep genomic analysis of malignant peripheral nerve sheath tumor cell lines challenges current malignant peripheral nerve sheath tumor diagnosisMiriam Magallón-Lorenz, Ernest Terribas, Sara Ortega-Bertran, et al.
European Journal of Medical Genetics|October 21, 2022
Genotype-phenotype associations in a large PTEN Hamartoma Tumor Syndrome (PHTS) patient cohortLinda A J Hendricks, Nicoline Hoogerbrugge, Hanka Venselaar, et al.
Cancers|March 13, 2024
Lifestyle Factors and Breast Cancer in Females with PTEN Hamartoma Tumor Syndrome (PHTS)Linda A J Hendricks, Katja C J Verbeek, Janneke H M Schuurs-Hoeijmakers, et al.
JAMA|November 19, 2009
Clinical and mutational spectrum of neurofibromatosis type 1-like syndromeLudwine Messiaen, Suxia Yao, Hilde Brems, et al.
Gastroenterology|June 28, 2015
Diagnosis of Constitutional Mismatch Repair-Deficiency Syndrome Based on Microsatellite Instability and Lymphocyte Tolerance to Methylating AgentsSahra Bodo, Chrystelle Colas, Olivier Buhard, et al.
Pageof 8